Last reviewed · How we verify
NCT05425823
Intervention to Promote Childhood Vaccinations and Influence Vaccination Attitudes
NA trial testing Health Belief Model Based Intervention in Vaccine Hesitancy in 54 participants. Completed in 19 January 2024.
30 December 2023
Quick facts
| Lead sponsor | Necmettin Erbakan University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 54 |
| Start date | 4 July 2022 |
| Primary completion | 30 December 2023 |
| Estimated completion | 19 January 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Health Belief Model Based Intervention
Conditions studied
- Vaccine Hesitancy — all drugs for Vaccine Hesitancy →
- Childhood Vaccination — all drugs for Childhood Vaccination →
Sponsor
Necmettin Erbakan University
Who can join
18 and older, female only, with Vaccine Hesitancy or Childhood Vaccination. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to determine the effect of pregnant women aged 18 years and older who have completed their 28th week of pregnancy and received intervention based on the Health Belief Model, on encouraging childhood vaccinations and influencing their vaccination attitudes, compared to pregnant women who receive standard care group. The 12-month vaccination rate of newborns and the change in their attitudes will be determined according to the Public Attitude Towards Vaccination Scale - Health Belief Model.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05425823
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vaccine Hesitancy
Currently open trials in the same condition.
- NCT06988969 — Predicting Vaccine Hesitancy Using Machine Learning · active not recruiting
- NCT06513494 — Active Health Education to Increase HPV Vaccine Coverage in Youth: A Stepped-wedge, Cluster, and Randomized Trial · NA · recruiting
- NCT06237374 — Supporting CHWs as Vaccine Educators: Impact of a Digital Training and Chatbot Intervention on Vaccination in Kenya · NA · active not recruiting
- NCT05910879 — RADx-UP Phase 3D (Oregon Saludable: Juntos Podemos) · NA · active not recruiting
Other Necmettin Erbakan University trials
Trials by the same sponsor.
- NCT07128407 — PMT-Based Radiation Safety Training for Nurses: Randomized Controlled Trial. · NA · active not recruiting
- NCT07504770 — Surgical Glove Compression to Prevent Paclitaxel Neuropathy · NA · not yet recruiting
- NCT07242807 — Minimally Invasive Prostate Interventions Registry (MIST Study) · not yet recruiting
- NCT07442331 — The Effect of Game-Based Learning on Identifying Cognitive Distortions and Interpersonal Communication Competence in Nur · NA · completed
- NCT07396038 — INTRAOPERATIVE BLADDER INJURY ASSESSMENT IN TURBT USING BICEP · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05425823 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Necmettin Erbakan University
- Last refreshed: 20 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05425823.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing